Notícias e Atividades da NextCure
Presença
NextCure é uma empresa listada sob o símbolo NXTC (US).
Executivos
Veja o organograma con seus 16 executivos principais
Biografias mais buscadas da NextCure
- Michael Richman, Director, President and Chief Executive Officer
- Elaine Jones, Director
- David Kabakoff, Chairman of the Board
Criar um alerta
para seguir os movimentos de executivos da NextCure.
Biotecnologia
NextCure possui 2.350 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e Genus (Reino Unido).
Popular M&A news in Biotecnologia
- Transcarent and Accolade have merged (publicado em 9 de abril de 2025)..
- Kashiv BioSciences acaba de anunciar uma arrecadação de fundos de 150 milhões de dólares. (publicado em 7 de abril de 2025).
- Atsena Therapeutics acaba de anunciar uma arrecadação de fundos de 150 milhões de dólares. (publicado em 4 de abril de 2025).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de NextCure
- NextCure Announces First Patient Dosed in the Phase 1 Study of LNCB74 (B7-H4 ADC) as Therapeutic for Treating Multiple Cancers - NextCure, Inc.
- NextCure Announces Acceptance of IND Application for LNCB74 - NextCure, Inc.
- Preclinical Data Demonstrates Anti-Siglec-15 Treatment Enhanced Generation of Quality Bone with Better Mechanical Properties in Mice with Moderate-to-Severe Osteogenesis Imperfecta - NextCure, Inc.
- NextCure Provides Business Update and Reports Third Quarter 2024 Financial Results - NextCure, Inc.
- NextCure Reports Preclinical Data for LNCB74 and Additional Clinical Biomarker Data for NC410 Combo at Society for Immunotherapy of Cancer Annual Meeting - NextCure, Inc.
- NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting - NextCure, Inc.
- NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024 - NextCure, Inc.
- NextCure Provides Business Update and Reports Second Quarter 2024 Financial Results - NextCure, Inc.
- NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - NextCure, Inc.
- NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024 - NextCure, Inc.
- View more press releases Close
Redes sociais sobre NextCure
- NextCure na Wikipedia, Google News e Yahoo Finance
- NextCure na LinkedIn, Twitter e YouTube
